Muscle creatine kinase-deficient mice by Ventura-Clapier, R. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/20682
 
 
 
Please be advised that this information was generated on 2017-12-05 and may be subject to
change.
T h e  J o u r n a l  o f  B io l o g ic a l  C h e m is t r y
© 1995 by The American Society for Biochemistry and Molecular Biology, Inc.
M uscle Creatine Kinase-deficient Mice
I. ALTERATIONS IN MYOFIBRILLAR FUNCTION*
(Received for publication, May 9, 1995)
R enée V entura-C lapier:|:§, Andrey V. Kuznetsov£li, Anne d/Albis||, J a n  van  Deursen**,
Bé Wieringa*** and Vladim ir I. V eksler til
From the ^Laboratoire de Cardiologie Cellulaire et Moléculaire, CJFINSERM 92-11, Faculté de Pharmacie, Université 
ParisSud, 92296 Châtenay-Malabry, France, ||[/RA CNRS 1131 Université Paris-Sud, 91405 Orsay} France, 
the **Département of Cell Biology and Histology, Faculty of Medical Sciences3 University of Nijmegen,
6500 HB Nijmegen, The Netherlands, and the HCardiology Research Center, 121552 Moscow, Russia
Vol . 270, No. 34, Issue of August 25, pp. 19914-19920, 1996
Printed in U.S.A.
The regulation of contractile activity in mice bearing  
a null m utation of the M-iso form of creatine kinase gene, 
has been investigated in  tissue extracts and Triton 
X-100-treated preparations of ventricular, soleus, and 
gastrocnemius muscles of control and transgenic m ice. 
Skinned fiber experiments did not evidence any statis­
tical difference in the maximal force or the calcium sen ­
sitivity of either muscle type. Rigor tension develop­
ment at a low MgATP concentration was greatly  
influenced by phosphocreatine in  control but not in  
transgenic mice as should be expected. In calcium -acti­
vated ventricular preparations, although the force devel­
oped by each cross-bridge was the same in control and 
transgenic animals, the rate constant of tension changes 
appeared to be markedly slowed in transgenic animals* As 
the ventricular isomyosin pattern was not altered, w e  
suggested that, in transgenic animals, cross-bridge cy­
cling was hindered by a local decrease in the MgATP to 
MgADP ratio, due to lack of a local MgATP regenerating 
system. Myokinase activity was not significantly changed 
while activities of pyruvate kinase or glyceraldehyde-3- 
phosphate dehydrogenase were found to be increased in  
transgenic animals. These results show that no funda­
mental remodelling occurs in myofibrils of transgenic an­
imals but that important adaptations modify the bioen- 
ergetic pathways including glycolytic metabolism.
Creatine kinase (CK) 1 is an important enzyme catalyzing the 
reversible transfer of a phosphate moiety between ATP and 
creatine. A major part of muscle creatine kinase exists as 
dimers composed of two subunits, M and B, giving three isoen­
zymes, MM, BB, and MB. In addition, there is a fourth isoen­
zyme in the mitochondria (mitochondrial CK), which differs 
biochemically and immunochemically from the cytosolic forms 
and can present octameric and dimeric structures (Wyss et al. , 
1992). Studies with sub cellular fractionation or histochemical 
localization have revealed that CK isoenzymes are present in 
cytosol or bound to intracellular structures. M-CK has been
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found in myofibrils and described as a structural protein of the 
M-band participating in the connections between myosin fila­
ments inside muscle fibers (Wallimann et a/., 1977). Additional 
binding sites have been described on actin filament (Wegmann 
et al. , 1992) or on the entire myosin filament (Otsu et al., 1989). 
M-CK activity in myofibrils is as high as about 2 IU/mg of 
protein in skeletal and ventricular muscles and represents 5% 
of total CK activity in fast-twitch muscle compared to 23% in 
ventricular muscle (Wallimann et a l 1977; Ventura-Clapier et 
a l ,  1987b; for review see Ventura-Clapier et a l  (1994)). M-CK 
has been shown to be functionally coupled to myosin ATPase. 
That means that myosin ATPase preferentially uses ATP sup­
plied by creatine kinase rather than cytosolic ATP (Bessman et 
al., 1980; Saks et al.} 1984). Myofibrillar CK can rephosphory- 
late all of the ADP produced by myosin ATPase (Saks et al., 
1976; Wallimann et a l.} 1984; Arrio-Dupont et a l 1992) and 
can provide enough energy for maximal force and normal ki­
netics even in the absence of MgATP, at the expense of phos- 
phocreatine (PCr) (Ventura-Clapier et al., 1987a; for review see 
Ventura-Clapier et al. (1994)).
The creatine kinase/phosphocreatine system is considered to 
fulfill important roles in the energy metabolism of skeletal and 
cardiac muscles (for reviews see Wallimann et al. (1992), Wyss 
et al. (1992), and Saks et al. (1994)). In skeletal muscles, activ­
ity pattern determines fiber type and metabolic profile. Fast- 
twitch (white) muscles exhibiting rapid and brief activity pat­
terns are mainly glycolytic and contain high amounts of PCr 
and CK (Iyengar, 1984; Yamashita and Yoshioka, 1991). By 
contrast, slow-twitch (red) skeletal muscle or cardiac muscle, 
exhibits prolonged and sustained activity associated with well 
developed oxidative metabolism and relatively low contents of 
PCr and CK. The organization of the CK system appears dif­
ferent in these two kinds of muscles; there is an abundance in 
cytosol of the muscle form of creatine kinase (M-CK) enzyme in 
fast-twitch muscle and compartmentation of the mitochondrial 
and M- isoenzymes in slow-twitch muscle and ventricle.
Functional consequences and adaptive strategies observed in 
animal models of long term deficiency in the CK system may 
give insights into the physiological role of this system in dif­
ferent muscle types. Long term alterations in the creatine 
kinase/phosphocreatine system have been developed by feeding 
animals with slowly metabolized analogues of creatine (/3-gua­
nidinopropionic acid, |3-GPAX These animals exhibit decreased 
PCr and ATP concentrations in cardiac and skeletal muscles 
(Shoubridge and Radda, 1984; Kapelko et aZ., 1988; Zweier et 
al.y 1991), In addition, a clear cardiac hypertrophy and isoen­
zyme shift from fast V3 to slow V3 myosin have been observed 
(Mekhfi et aZ., 1990). Adaptive strategy in the heart is directed 
toward an increase in the number of contractile units together 
with an increased efficiency of each unit to respond to de­
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creased metabolic fluxes. In the same animal model, skeletal 
muscles exhibited an enhanced oxidative metabolism and an 
isomyosin shift from fast- to slow-type isomyosins (Shoubridge 
et al., 1985; Moerland et al., 1989).
More recently, a mouse line bearing a null mutation of M-CK • _ _ 
has been developed (van Deursen et al., 1993). Genetic M-CK 
knocking out is a unique model of complete isoenzyme-specific 
CK deficiency in contrast to GPA feeding, a model of substrate 
deficiency. Another important difference between these two 
models is that mutant muscles keep mitochondrial and, in 
principle, brain isoforms of CK which could participate in en­
ergy metabolic pathways. It was shown that M-CK deficiency 
does not lead to compensatory overexpression of other CK 
isoenzymes. Muscles from these mice, which do not express the 
muscle form of CK, are able to use PCr but lack the ability to 
perform burst activity. In order to get insights into the func­
tional characteristics and possible adaptational processes at 
the level of myofibrils in these transgenic mice, we character­
ized intrinsic mechanical properties of ventricular, soleus, and 
gastrocnemius muscles using the skinned fiber technique 
which allows us to investigate myofibrillar properties without 
interference with cytosolic substrate and ion changes. The re­
sults show that intrinsic mechanical capacities and calcium 
sensitivity were maintained in transgenic animals, although 
skinned fibers were not able to utilize PCr. However, contract­
ile kinetics were markedly slowed down despite an unchanged 
myosin isoenzyme profile. In addition, the energy supply pat­
tern was changed since glycolytic capacity seemed to increase 
in fast-twitch muscle as well as in ventricular muscle.
MATERIALS AND METHODS 
Mouse Model o f  Muscle Creatine Kinase-deficient Mice
Mice bearing a null ihutation of the M-CK gene were obtained as 
described previously (van Deursen et a l ,  1993). Heterozygous mutants 
were interbred to generate mice deficient in M-CK. Offsprings were 
genotyped 2 weeks after birth.
Six control adult female mice C57BL/6 and 5 adult transgenic mice 
were anesthetized with an intraperitoneal injection of pentobarbitone 
according to the recommendations of the Institutional Animal Care 
Committee (INSERM, Paris, Prance) and weighed. While under anes­
thetics, animals were exsanguinated, and various organs were isolated 
and weighed. Heart, gastrocnemius, and soleus muscles were placed in 
a modified Krebs solution containing (mM): NaCl, 118; KC1, 4.7; 
NaHC03, 25; KH2P 0 4) 1.2; and MgS04, 1.2.
Organ samples were frozen for further analysis. Other samples were 
minced with scissors, placed into cold solution (50 mg wet weight per 1 
ml) containing (mM): K^HPO^ 100 (pH 8.7); EGTA, 1; JV-acetyl cysteine, 
15; and homogenized in a Ultra-Turrax homogenizer. Tissue homoge- 
nates were incubated for 60 min at 0 °C for complete extraction of CK and 
other enzymes, centrifuged at 13,000 X g  for 20 min, and the supernatant 
was used for determination of CK and myokinase and frozen,
Mechanical Experiments
Muscle Preparation—Muscle fiber bundles were dissected from so- 
leus or gastrocnemius or from papillary muscles of the left ventricle of 
mice in a zero-Ca2+ Krebs solution, pH 7.4. Bundles were incubated for 
1 h in a relaxing solution (pCa 9, see solutions below) containing 1% 
Triton X-100 to solubilize the membranes and were then transferred to 
the relaxing solution without detergent and kept at 4 °C until use. After 
the skinning procedure, one bundle was snared at both ends with hair 
emerging from stainless steel tubes in the experimental apparatus. It 
was adjusted to slack length, stretched by 20%, and subjected to an 
activation/relaxation cycle. Sarcomere length was controlled by laser 
diffraction (10-milliwatt He-Ne laser, Spectra-Physics, Inc., Mountain 
View, CA). The length and diameter of the muscles were measured by 
use of a graticule in the dissecting microscope. Muscles were immersed 
in 2.5-ml chambers arranged around a disk in a temperature-controlled 
bath positioned on a magnetic stirrer. Each solution was well stirred at 
high speed. All experiments were performed at 22 °C.
Experimental Apparatus—The tubes were connected to a transducer 
(model AE 801, SensoNor Microelectroniks, Horten, Norway) and a 
vibrator as described previously (Mayoux et al., 1994). The bandwidth
of the transducer and tube was 2 kHz. The permanent magnet and coil 
came from a standard loudspeaker (Pioneer TS-130A, Pioneer Electric 
and Research Corp., Forest Park, IL). The coil was glued to a glass tube 
axis (2 mm in diameter) driven in an axial ball bearing (total moving 
mass < 1.5 g). A flag with a narrow window was glued on the glass axis 
between a lamp and a position detector (type S1543, Hamamatsu, 
Japan), allowing measurements of the displacement length. A feedback 
with the length signal combined with a power amplifier allowed control 
of muscle length. The system had a rise time of about 1 ms without 
overshoot. Length and tension changes were monitored on a digital 
storage oscilloscope (OS4020, Gould, Inc., Cleveland, OH). Tension trac­
ings were digitized at 20 kHz (12-bit analog/digital converter), analyzed 
on-line using a PC compatible computer, and stored on a videotape.
Solutions—Solutions were calculated using the computer program of 
Fabiato (1988). All solutions were calculated to contain (mM): EGTA, 10; 
imidazole, 30; Na+, 30.6; Mg2'*', 3.16; and dithiothreitol, 0.3; ionic 
strength was adjusted to 0.16 m with potassium acetate. pH was adjusted 
to pH 7.1 with acetic acid. In relaxing and rigor solutions, pCa was 9. In 
activating solution, pCa was 4.5. Relaxing and activating solutions also 
contained 3.16 mM MgATP and 12 mM PCr. Rigor solutions were obtained 
by mixing two solutions of p MgATP 2.5 and 6 or pMgATP 4 and 6. 
EGTA was obtained from Sigma. PCr (Neoton, Schiapparelli Farma- 
ceutica SEARLE, Turin, Italy) was a kind gift of Prof. E. Strumia.
Experimental Protocols
pCalTension Relations—pCa/tension relations were determined un­
der isometric conditions by briefly placing each fiber into solutions of 
increasing calcium concentration until maximal tension was reached. 
Data were fitted using linearization of the Hill equation for relative 
tensions above 10% and under 90% as follows: T  — [Ca2+]n/(iT + 
[Ca2 ' ]") were T is relative tension, K  a constant, and n the Hill coeffi­
cient, n and pCa for half-maximal activation (pCaco = -1 og10K/n) were 
calculated for each fiber by means of linear regression analysis. Resting 
tension was measured at pCa 9. Active tension (expressed as mN/mm2) 
was the total tension at pCa 4.5 minus resting tension.
pMgATP/Rigor Tension Relations—pMgATP/rigor tension relations 
were established by stepwise decreasing ATP concentrations until max­
imal rigor tension was obtained. The fiber was then placed in the 
relaxing solution for 10 to 15 min before a new set of rigor solutions was 
applied. Data were fitted using the Hill equation. The pMgATP for 
half-maximal rigor tension, pMgATP50 ~  (—log1QK)/nf was calculated 
for each experimental condition using linear regression analysis.
Stiffness and Kinetic Measurements—To determine fiber bundle stiff­
ness and the rate constant of tension recovery in cardiac preparations, 
quick length changes (0.3-3% of initial muscle length) were applied in 
the relaxing and activating solutions. Twelve successive stretches and 
releases were made, starting with the relaxing solution. Only responses 
to stretches were used for calculations. Each value for each fiber was 
the mean of five to seven stretches of varying amplitudes performed in 
a given experimental condition. The spike of tension in phase with the 
length change characterized the elastic phase (Huxley and Simmons, 
1971). Stiffness was the extreme tension reached during stretching 
(mN/mm2) divided by the length change (/im ). A first series of length 
changes was imposed in the relaxing solution to assess passive proper­
ties of each fiber. Resting stiffness was calculated by linear regression 
analysis on the responses to stretches. Then a second sei’ies of length 
changes was initiated in control activating solution. The tension level 
before the first stretch was taken as the maximal tension and used for 
normalizations. Active or rigor stiffness were calculated as the differ­
ence between total stiffness minus resting stiffness. The rate constant 
of tension recovery after quick stretches was calculated by a least 
square regression analysis, according to a single exponential model, 
between 50% and 80% of recovery and using stretches of more than 1%.
Enzym e A nalysis
Enzyme activities were determined spectrophotometrically at 340 
nm (Gilford Spectrophotometer, Corning, NY), 30 °C, by using coupled 
enzyme systems. Results are given in IU/g wet weight. Myokinase 
activity was determined at pH 7.1 using the coupled enzyme assay of 
hexokinase and glucose-6-phosphate dehydrogenase producing 
NADPH, Activity was assayed in a medium containing (in mM): 
HEPES, 20; MgCl2, 6; dithiothreitol, 0.5; ADP, 1.2; glucose, 20; NADP, 
0.6; and 2 IU/ml glucose-6-phosphate dehydrogenase and hexokinase. 
Glyceraldehyde-3-phosphate dehydrogenase was determined at pH 7.6, 
in a medium containing (in mM): triethanolamine, 82.5; 3-phosphoglyc- 
erate, 6; ATP, 1.1; EDTA, 0.9; M gS04, 1.7; NADH, 0.2; and 15 IU/ml 
3-phosphoglycerate kinase. Pyruvate ldnase activity was measured at
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Table I
Anatomical data of control and M-CK* deficient mice
Values are mean ± S.E.
Body Heart Liver Kidney Lung HW/BWa
8 mg mg mg mg mglg
Control (5)6 27.0 ± 1.3 155 ± 14 1223 ± 94 376 ± 28 171 ± 14 5.73 ± 0.34
Transgenic (5) 25.3 ± 1.0 135 ± 6 1145 ± 88 347 ± 19 178 ± 9 5.34 ± 0.11
(NS)C (NS) (NS) (NS) (NS) (NS)
“ HW/BW, heart weight/body weight ratio. 
h Numbers in parentheses, number of animals. 
c NS, not significant.
pH 7.6 in a medium containing (in him): triethanolamine, 82.5; phos- 
phoenolpyruvate, 0.54; M gS04, 2.5; KC1,10; ADP, 4.7; NADH, 0.2; and 
9.2 IU/ml lactate dehydrogenase, Fructose-6-phospholdnase was deter­
mined at pH 8.5 in a medium containing (in him): Tris-HCl, 70; M gS04, 
1.4; KC1, 4.5; phosphoenolpyruvate, 0.71; fructose 1,6-diphosphate, 0.64; 
fructose 6-phospl\ate, 1.8; ATP, 1.1; NABH, 0.2; and 9.6 IU/ml lactate 
dehydrogenase and 4.2 IU/ml pyruvate kinase. Lactate dehydrogenase 
activity was determined at pH 7.4 using a medium containing (in him): 
KHgPO^ 20; KC1, 120; dithiothreitol, 0.5; pyruvate, 10; NADH, 0.2.
Myosin Iso forms
Myosin Preparation—Frozen muscles were thawed on ice, cut into 
small pieces, and washed with 5 volumes of 20 mM NaCl, 5 mM sodium 
phosphate, and 1 mM EGTA (pH 6.5). Myosin was then extracted with  
3 volumes of 100 mM sodium pyrophosphate, 5 mM EGTA, and 1 mM 
dithiothreitol (pH 8.5); after 30 min of gentle shaking, the mixture was 
centrifuged at 10,000 x g, The supernatant containing myosin was di­
luted with 1 volume of glycerol and stored at -2 0  °C (d’Albis et a l } 1979).
Electrophoresis o f  Native Myosin Isoforms—Gel running buffer con­
sisted of 20 mM sodium pyrophosphate (pH 8.5), 10% glycerol, 0.01% 
2-mercaptoethanol, and 2 mM MgCl2, Cylindrical (6 X 0.5 cm) gels 
contained 4% polyacrylamide (3.88% acrylamide and 0,12% A^AT-meth- 
ylenebisacrylamide). Between 1 and 5 fxg of myosin was loaded on each 
gel. Electrophoresis was carried out at a constant voltage of 90 V, for 22 
h, between 0 and 2 °C (d’AIbis and Gratzer, 1973; Hoh, 1975),
Electrophoresis o f Myosin Heavy Chains and Quantification—Elec­
trophoresis was performed as described by Talmadge and Roy (1993). 
Minigels were used in the Bio-Rad Mini-PROTEAN II Dual Slab Cell, 
Electrophoresis took place in a cold cupboard, at 10 °C for 28 h, The gels 
were stained with Coomassie Blue R-250, and the relative amounts of 
the different myosin heavy chains were measured using a densitometer 
equipped with an integrator.
Statistical Analysis
Values were expressed as mean ±  S.E. Student’s t test was used to 
compare the means between control and transgenic animals or inside 
groups between two experimental conditions. Statistical significance 
was reached when p  <  0.05.
RESULTS
Anatomical Data—Comparing control and transgenic mice, 
no statistical difference was observed between heart, lung, 
liver, kidney, and body weights (Table I). The heart weight to 
body weight ratio was in consequence not altered in transgenic 
animals. Thus, no sign of organ dysfunction or change in mus­
cle mass or cardiac insufficiency could be detected.
Tension and Calcium Sensitivity of Skinned Fibers—Fibers 
of similar diameter were dissected from control and transgenic 
mice. Diameters were, respectively, for control and transgenic: 
207 ± 23 and 179 ± 16 /urn for ventricle, 160 ± 15 and 138 ±  
2 0  fim for soleus, 155 ± 26 and 170 ± 26 /llm for gastrocnemius. 
No statistical difference was observed, which allowed accurate 
comparison of mechanical performances. Table II shows me­
chanical parameters of skinned fibers, normalized per cross- 
sectional area, in resting (pCa 9) and activating (pCa 4.5) condi­
tions. Whatever the muscle, resting tensions were not modified in 
transgenic animals. Although clear differences existed between 
active forces developed by the different muscles, no differences 
were observed between control and transgenic animals.
Each fiber bundle was submitted to a set of solutions of
increasing calcium concentrations (see “Materials and Meth­
ods”), and pC a/tension relations were calculated according to 
the Hill equation. Mean pCa for half-maximal activation 
(pCa50) and n values are reported in Table II. No significant 
change in calcium sensitivity could be detected except a small 
increase in Hill coefficient in gastrocnemius muscle.
It is known, however, tha t inactivation of myofibrillar CK, 
either by inhibition or in  the absence of PCr, leads to a change 
in the calcium/tension relationship. This was confirmed in car­
diac fibers of control mice (Fig. 1) where omission of PCr in 
activating solution led to an increase in calcium sensitivity 
from 5.68 ± 0.03 to 5,98 ± 0.03 (n = 4, p <  0.001).
Effect of Phosphocreatine on Relaxation of Rigor Tension— 
The next series of experiments was undertaken to study the 
influence of PCr on the relaxation of rigor tension in control 
and transgenic muscles. Rigor tension is the tension induced in 
the virtual absence of calcium by decreasing MgATP concen­
tration, We have shown in ventricular muscle tha t the devel­
opment of rigor tension is greatly influenced by CK bound in 
myofibrils. The concentration of MgATP necessary to obtain 
half-maximal rigor is greatly reduced when PCr is provided as 
a substrate. In order to characterize more precisely this effect 
in control and transgenic mice, complete pMgATP/rigor tension 
relations have been established in presence or absence of PCr 
in sets of solutions of decreasing MgATP concentrations. In Fig.
2, pMgATP/rigor tension relations have been drawn using Hill 
equation and pMgATP50 (pMgATP for half-maximal rigor 
force) values given in Table II for ventricle, soleus, or gastro­
cnemius. When PCr was added, a clear shift of the relation was 
observed in control muscles. While pMgATP/tension relations 
without PCr were identical in control and transgenic animals, 
no shift could be evidenced in the presence of PCr for the three 
muscle types of transgenic animals. pMgATP50 values in the 
presence of PCr, as well as CK efficacy, which is defined as the 
difference between pMgATP50 values in the presence and ab­
sence of PCr, were both highly significantly different between 
control and transgenic mice (Table II). This result is in com­
plete agreement with the absence of M-CK in these animals 
and clearly shows that myofibrils from transgenic mice have no 
enzyme able to utilize PCr.
Responses of Ventricular Skinned Fibers to Quick Length 
Changes—Active stiffness as measured by the tension re­
sponses to a quick length change was not significantly different 
in ventricular fiber bundles of control and transgenic mice (450 
± 5 7  mN/pan/mm2 (n = 8 ) versus 644 ±69 rrw/pm/mm2 (n = 6 ) 
respectively). It should be noted, however, that a small tend­
ency toward an increase in both tension and stiffness could be 
observed, although not reaching significance, possibly as a 
result of poor estimation of the fibers’ effective cross-section. 
However, the ratio of force to stiffness was not altered (Fig. 3) in 
transgenic mice showing that force developed by each cross- 
bridge was preserved. When a length perturbation was applied to 
activated muscle, force first increased in phase with the increase 
in length and then decreased toward the value of the tension
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Table II
Mechanical characteristics of skeletal and cardiac skinned fibers from control and M-CK-deficient mice 
Values are mean ±  S.E.
Resting tension Active tension pCaG0 nH /jATP 50 pATP50 + PCr c i v
m-N / mm2 mNf film2
Ventricle
Control
Transgenic
3.35 ± 0.68 (8)6 
3.27 ± 0.60 (7) 
(NS)C
37.9 ± 4.4 (8) 
47.2 ± 3.3 (7) 
(NS)
5,723 ± 0.041(10) 
5.761 ± 0.027(7) 
(NS)
2.83
2.75
± 0.16 (10) 
± 0.22 (7) 
(NS)
3.44 ± 0,07 (8) 
3.47 ± 0.08 (8) 
(NS)
4.99 ± 0.05 (8) 
3.58 ± 0.03^ (8)
1,55
0.11
± 0.09 (8) 
± 0.06* (8)
Soleus
Control
Transgenic
5.82 ± 0,63 (6) 
6.99 ± 1.81 (6)
(NS)
103 ± 21 (6) 
123 ± 23 (6) 
(NS)
5.825 ± 0.074(8) 
5.745 ± 0.052 (6) 
(NS)
3.12
4.00
± 0.28 (8) 
± 0.68 (6) 
(NS)
3.65 ± 0.07 (8) 
3.87 ± 0.07 (5) 
(NS)
4,90 ±  0.03 (8) 
3,92 ± Q.10d (5)
1.25
0.05
± 0.07 (8) 
± 0.06^ (5)
Gastrocnemius
Control
Transgenic
13,3 ± 6,1(4) 
7,8 ± 2.0 (7) 
(NS)
275 ± 47 (6) 
155 ± 28 (7) 
(NS)
5.849 ± 0.082 (8) 
5.937 ± 0,043 (7) 
(NS)
3.20
5.10
± 0.29 (8) 
± 0.59* (7)
3.43 ± 0.08 (6) 
3.55 ± 0.05 (8) 
(NS)
4,98 ± 0.10(6) 
3.57 ±  0.10d (8)
1.56
0.02
± 0.06 (6) 
± 0.09c£ (8)
° CKeff, efficacy of creatine kinase expressed as a pMgATP50 value at 12 m M  PCr minus the value at 0 m M  PCr. 
6 Numbers in parentheses, number of fibers, 
c NS, not significant.
d p  < 0.001 relative to respective value for fibers of control mice, 
a p  <  0.05 relative to respective value for fibers of control mice.
12 inM VCv
0 m[VI PCr
Fig. 1. Original tension recording of the responses of a control 
mouse skinned ventricular fiber to an increase in calcium con­
centration in  the presence or in the absence of PCr. Letters 
represent different p C a values; a, 9; b , 6.25; c, 6,125; d f 6; e, 5.875; /, 
5.75; g, 5.625; h, 5.5; i, 5.375;y, 4.5. Diameter of the fiber was 210 ¡xm. 
Resting tension was 4.88 mN/mm2. Tmax was 30,1 mN/mm2. pCa50 and 
Hill coefficient were, respectively, 5.72 and 2.04 in the presence and 
6.01 and 1.51 in the absence of PCr. Notice that active tension devel­
oped for lower calcium concentrations in the absence of PCr.
before the length change. The rate constant of tension recovery 
reflects the cross-bridge cycling rate, while the extent of recovery 
characterizes the cross-bridge state. The rate constant of tension 
recovery following stretches was greatly decreased in transgenic 
mice compared to control while the extent of recovery was not 
different (Pig. 3). This result suggests a decrease in the cross­
bridge cycling rate in transgenic ventricular fibers.
Indeed, inhibition of myofibrillar CK slows down tension 
kinetics in skinned rat cardiac muscle, probably due to local 
accumulation of protons and MgADP (Ventura-Clapier et al., 
1987b). This was also observed in mouse heart where with­
drawal of PCr decreased the rate constant from 103 ± 17 s - 1  to 
38 ± 4 s“ 1 (n = 4, p  < 0.05).
Isomyosiyi Patterns—A decrease in cross-bridge cycling rate 
may arise from an altered pattern in myosin isoenzyme distri­
bution. In order to see if transgenic animals exhibit a change in 
myosin isoforms, the myosin phenotype was determined in the 
different muscles.
Two types of gel electrophoresis were used to analyze the 
content in myosin isoforms of the cardiac and skeletal muscles, 
respectively. The cardiac ventricular myosins are best sepa­
rated by gel electrophoresis under nondissociating conditions 
(Lompre et al., 1981), as shown here in a control rat heart, 
which displayed the three isoforms VI, V2, and V3 (Fig. 4a),
ZoCOzLUh-COo
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§
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pMgATP
Fig. 2. Graphs showing relative pMgATP/rigor tension rela­
tions with or without PCr, obtained in ventricular (V), soleus 
(S), and gastrocnemius (G) skinned fibers from control (co n tin ­
uous lines)  and mutant mice (d a sh ed  lines),  pMgATP versus rigor 
tension relations were calculated and plotted according to the Hill 
equation T -  Kt(K + [MgATP]'1), where T  is relative tension, K  is 
a constant, and n the Hill coefficient. Each curve w as drawn using 
the means of the n values and pMgATP for half-maximal tension 
(pMgATPr>0) calculated for each fiber and averaged in Table II, 
Arrows indicate CK efficacy values in control animals. Addition of 
PCr (solid lines) was able to shift the pMgATP/tension relation of all 
muscles of control animals but not of mutant animals.
Both control and transgenic mouse ventricles displayed only 
the VI isoform.
To analyze the myosin isoform content in the skeletal mus­
cles, gel electrophoresis in the presence of SDS allowed the 
separation of the slow type isoform 1 and the three fast type 
isoforms 2 (Fig. 46), The only transgenic mouse soleus muscle 
contained the 2 A and the 1  isoforms in the same proportions, 
35% and 65%, respectively, as the control muscle. The gastro-
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Fig. 3, Mechanical characteristics of ventricular skinned fi­
bers from control and transgenic mice measured using the  
quick length change technique, k is the mean of the rate constants 
of tension changes following stretches of different amplitudes; TR is the 
level of tension recovery following stretches expressed in percent of 
tension changes; F/S is the force to stiffness ratio determined for each 
fiber. Only the rate constant of tension changes was decreased in 
mutant mice while the other properties were preserved.
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Fig. 4. A, gel electrophoresis of cardiac ventricular native myosin, a, 
control mouse ventricle, b, transgenic mouse ventricle, c, rat ventricle. 
VI, V2, and VS designate the three types of ventricular myosin, B, 
myosin heavy chains of soleus and gastrocnemius muscles, a, control 
mouse soleus. 6, transgenic mouse soleus. c, control mouse gastrocne­
mius. d, transgenic mouse gastrocnemius. 2A, 2X, 2B, and 1 designate 
the four types of skeletal muscle myosin heavy chains.
cnemius muscles mainly contained the 2B isoform, 94 ± 2 % (n 
= 4) in the control mice and 89 ± 2% (n ~  4) in the transgenic 
mice; the difference was not significant. The remaining myosin 
was distributed between a trace of the slow-type 1 isoform and 
the two other fast-type 2A and 2 X isoforms.
Glycolytic Enzymes and Myokinase Determinations—Since 
no change in isomyosin pattern could be detected in muscles of 
transgenic mice, the question arose as to how MgATP and 
MgADP concentrations could be controlled in transgenic ani­
mals, Indeed, it has been shown that myofibrillar CK, by keep­
ing high ATP/ADP ratio and low proton concentrations close to 
myosin ATPase, ensures optimal efficiency of myosin ATPase 
in  skeletal (Bessman et al., 1980) as well as cardiac muscle 
(Ventura-Clapier et a l , 1987a, 1987b). Other MgATP regener­
ating enzymes may exist in cytosol or may be loosely bound to 
myofibrils. To check for possible overexpression of such en­
zymes, glycolytic enzymes as well as myokinase activities were 
measured in the different muscles. Results are shown in Table 
III. Myokinase activity was not significantly increased in trans­
genic animals while some glycolytic enzymes like pyruvate 
k inase and glyceraldehyde-3-phosphate dehydrogenase in­
creased in ventricles and glyceraldehyde-3-phosphate dehydro­
genase and lactate dehydrogenase increased in gastrocnemius. 
N o  significant changes were seen for soleus muscle.
DISCUSSION
In this study, attempts were made to characterize the intrin­
sic properties of cardiac and skeletal myofibrils of mice bearing 
a null mutation for the M-form of CK. Skinned fiber technique 
was used to destroy cellular membranes, while keeping the 
cellular architecture intact, so th a t intrinsic mechanical prop­
erties of the myofibrillar network, in a definite medium sur­
rounding myofibrils, could be investigated. The results showed 
that maximal force and stiffness characteristics were not al­
tered while kinetics of force changes assessed in ventricular 
tissue were markedly reduced despite an unchanged isomyosin 
profile. Sensitivity to added ATP was not altered, while addi­
tion of PCr was without effect in mutants, suggesting no un­
known route for PCr utilization inside myofibrils. Increased 
glycolytic activity could be one possible adaptational way to 
control the ATP/ADP ratio inside myofibrils devoid of bound 
CK during contraction.
Muscle contraction is the result of cyclic association between 
the thin and thick filaments resulting in the relative sliding of 
these filaments past each other when muscle is allowed to 
shorten, or resulting in force development in isometric condi­
tions. This mechanical interaction or cross-bridge cycling is 
coupled to the hydrolysis of ATP to ADP by myosin ATPase 
located on the thick filament and regulated by the binding of 
calcium to the troponin complex of the thin filament. The 
products of ATP hydrolysis are released when myosin is at­
tached to actin during the power stroke portion of the cycle, and 
an increase in hydrolytic products such as ADP, inorganic 
phosphate, and H 4* is expected to influence the different steps 
and thereby the power stroke. Earlier studies have shown that 
MgADP increases isometric tension and calcium sensitivity 
and decreases maximal velocity of shortening or kinetics of 
force development (Brandt et a l 1982; Cooke and Pate, 1985; 
Ventura-Clapier et a l ,  1987a; Hoar et a l , 1987). ADP detach­
ment is considered to be the rate-limiting step in cross­
bridge detachment and for the overall cross-bridge cycle 
(Siemankowski et al., 1985). ADP accumulation may inhibit the 
interaction between actin and myosin by competing with 
MgATP at the active site of the myosin molecule, thus slowing 
down MgADP detachment and further MgATP binding and 
cross-bridge detachment (for review see Ventura-Clapier et a l  
(1994)).
The rate constant of tension recovery following stretches is 
an estimate of the kinetics of cross-bridge cycling and reflects 
the rate-limiting step in the cycle; i t  was shown to vary with 
myosin isoform composition as well as following alterations in 
concentrations of substrates or products of myosin ATPase 
(Ventura-Clapier et al., 1987a; Mekhfi and Ventura-Clapier, 
1988; Mayoux et a l., 1994). We have observed a 3-fold decrease 
in cross-bridge cycling rate in cardiac myofibrils of transgenic 
animals compared to control without any shift in myosin iso­
forms. A similar change was observed in control mice when PCr 
was omitted in the solution. Thus, this decreased rate of force 
changes can be attributed to changes in ATP/ADP ratio in the 
vicinity of myosin ATPase with a consequent product inhibition 
of ATPase activity. Accumulation of MgADP as a result of a 
lack of myofibrillar CK will induce an increase in force produc­
tion and a  decrease in rate of cross-bridge cycling, leading to a 
lower energy consumption and better economy of force produc­
tion. As a consequence, the rates of force production and relax­
ation of the muscle twitch would be decreased. However, for 
cardiac muscle having cyclic activity, this would tend to in­
crease the end-diastolic pressure and to decrease the ventric­
ular filling, except if the intrinsic heart rate is decreased. 
Unfortunately, no information are as yet available concerning 
heart rate, developed pressure, or the force-length relationship
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Table III
Energy metabolism of skeletal and cardiac muscle from control and M-CK-deficient mice
Values are expressed in IU/min/g wet weight. Values are mean ± S.E.
Myokinase Fructose-6-phosphokinase Pyruvate kinase
Glyceraldehyde-P
dehydrogenase
Lactate
dehydrogenase
Ventricle
Control
Transgenic
96 ± 11 (5) 
120 ± 12 (5)
2.05 ± 0.31 (4) 
2.71 ± 0 .77 (4 )
37.4 ± 6 .2  (4) 
74 ± 12“ (5)
2.31 ± 0.48 (4) 
8.49 ± 0.42* (5)
52 ±  14 (3) 
69 ±  11 (5)
Soleus
Control
Transgenic
214 ± 21 (5) 
237 ± 43 (5)
2.14 ±0 .37  (3) 
2.08 ± 0.48 (4)
69 ± 30 (2) 
111 ± 26(5) 14.6 ± 4.1 (3)
66.6 ± 4.3 (3) 
69 ± 11 (3)
Gastrocnemius
Control
Transgenic
235 ± 24 (5) 
334 ± 47 (5)
7.9 ± 2 .9 (3 )  
21.3 ± 6.7(5)
251 ± 5 1  (3) 
372 ± 28 (5)
8.4 ± 1.0 (4) 
16.2 ± 1,7C (10)
239 ± 10 (3) 
342 ± 24" (5)
a p  <  0.05 relative to respective value in control mice. 
b p  <  0.001 relative to respective value in control mice. 
c p  <  0.01 relative to respective value in control mice.
of cardiac muscle in transgenic animals. Although the cross­
bridge cycling rate of skeletal muscle could not be determined 
in this study, it is highly probable that tension kinetics would 
be slowed also. Further studies are needed to clarify the con­
traction kinetics of the intact muscles in these animals.
In Triton X-100-treated fibers, loosely bound enzymes are 
usually detached from the myofibrillar structures. In intact 
cells, many enzymes including glycolytic enzymes, AMP deami­
nases, and myokinase are bound to myofibrillar proteins, mainly 
to the thin filament, and may participate in MgADP/MgATP 
regulation in myofibrils (Maughan and Godt, 1989). Indeed, we 
observed in total tissue extracts of both cardiac and skeletal 
muscles of transgenic mice, an increase in glycolytic enzyme 
activities, with no increase in total myokinase activity. It is thus 
possible that a fraction of these enzymes is bound to myofibrils 
in vivo and ensures local rephosphorylation of MgADP.
When PCr was omitted, it was clear that calcium sensitivity 
of control cardiac fibers was increased. Such a result was al­
ready obtained in rat heart (Ventura-Clapier et a l , 1987 a) and 
is due to cross-bridge slowing and cooperative interaction be­
tween attached cross-bridges. Surprisingly, such an increased 
calcium sensitivity was not observed in soleus, gastrocnemius, 
or ventricular muscles of transgenic mice, and a similar force/ 
calcium relationship was observed in control and transgenic 
muscles, suggesting that another mechanism compensated for 
the increased calcium sensitivity following changes in the local 
ATP/ADP ratio. Calcium sensitivity is determined by the bind­
ing of calcium to troponin C as well as by interactions between 
the other constituents of the thin filament. Calcium sensitivity 
of cardiac or skeletal muscle is developmental^ regulated, and 
the role of troponin T isoforms is often put forward to explain 
changes in calcium sensitivity in spite of unchanged troponin C 
expression (Solaro et a l , 1988; Nassar et a l ,  1991; Pan and 
Potter, 1992). One may suggest that a phenotypic change in the 
proteins constitutive of the thin filament will participate in 
maintaining constant calcium sensitivity in these transgenic 
muscles. Alternatively, at least in cardiac muscle, cAMP-medi- 
ated phosphorylation of the inhibitory unit of troponin (tropo­
nin I) decreases the sensitivity of myofibrils for calcium by 
diminishing the Ca2+-affinity of troponin C (Ray and England, 
1976). Phosphorylation of troponin I has been shown to be very 
stable (Garvey et a l ,  1988). It may thus be possible that myo­
fibrils of transgenic mice exhibit an enhanced phosphorylation 
level of contractile proteins which would decrease calcium sen­
sitivity and compensate for the change induced by the altered 
ATP/ADP ratio inside myofibrils. Unfortunately, experimental 
data in support of such a hypothesis are lacking.
The skeletal muscle function of mice deficient in muscle CK 
has been investigated previously (van Deursen et al., 1993). 
Mice lacking M-CK have lost the ability to sustain maximal
force output during short periods of high work, while appar­
ently being adapted for endurance exercise. However, cardiac 
function of mutant mice has not been investigated at present. 
To elucidate the role of the CK system in energy metabolism, 
other strategies designed to reduce the activity of the CK sys­
tem were used, such as feeding animals with creatine analogs. 
This affects the creatine ldnase/phosphocreatine system at the 
substrate site. Alternatively, acute iodoacetamide poisoning of 
CK has also been used (Fossel and Hoefeler, 1987; Kupriyanov 
et a l , 1991). In these models, where the function of isolated 
heart was impaired, a decreased developed pressure and rate 
pressure product were described (Mekhfi et a l , 1990; Zweier et 
al., 1991). Furthermore, impairment of diastolic function and a 
steeper rise in stiffness at increased afterloads in association 
with increased energy breakdown were observed (Kapelko et 
al,, 1988; Kupriyanov et a l 1991). Even more interesting was 
the observation, in these models, of phenotypic conversion of 
fast-twitch to slow-twitch fibers in skeletal muscle together 
with isomyosin transitions (Moerland et a l ,  1989) and cardiac 
enlargement and increased economy of contraction by a shift 
from the fast isoform of myosin to the slow isoform in heart 
(Mekhfi et a l,, 1990). It could be concluded that CK/PCr system 
alterations induce contractile abnormalities and that alter­
ations in metabolic state per se3 may lead to changes in the 
expression of contractile proteins.
No obvious change in size and distribution of the three fiber 
type populations was observed in M-CK-deficient mice (van 
Deursen et al., 1993). However, M-CK-deficient type 2 A and 2B 
fibers exhibited a clear metabolic phenotype change by elabo­
rating an inter myofibrillar mitochondrial network, with a high 
number of relatively large mitochondria, the potential for aerobic 
energy generation being increased approximately twice (Veksler 
et al, 1995) explaining improved endurance performance during 
low intensity exercise (van Deursen et a l , 1993). In addition, we 
showed in the companion paper that mitochondria in ventricular 
and soleus muscles from transgenic mice have an increased sen­
sitivity to ADP (Veksler et a l , 1995). Increase in mitochondrial 
content in “glycolytic” muscles and increased sensitivity to 
ADP in “oxidative” muscles appear to represent adaptations 
toward increased energy turnover via the adenylate pathway.
Absence of marked isomyosin shift, either in skeletal or 
cardiac muscle in M-CK knocked out mice is in contrast with 
what was observed in ra t cardiac or mice skeletal muscles 
following 0 -GPA feeding (Shoubridge et a l , 1985; Moerland et 
a l , 1989; Mekhfi et a l y 1990). In these situations, a better 
economy of contractile force development was achieved by a 
switch from fast to slower myosin isoforms. The reason for such 
a difference is not straightforward. Despite the absence of an  
isomyosin shift in mouse heart following /3-GPA feeding, these 
hearts can potentially switch totally from fast to slow myosin
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as has been shown under the influence of hypothyroidic trea t­
ment (Ng et a l ,  1991). The main difference between the two 
models is that ATP as well as PCr contents are preserved in the 
case of the M-CK mutation in comparison with /3-GPA feeding 
where both compounds appear to be decreased. A consequence 
of this would be that the expression of proteins of the contract­
ile apparatus is more under the control of the concentrations of 
metabolites. On the other hand, it should be borne in mind th a t 
targeted mutations affect the animals in the early embryonic 
life where the potentialities for adaptations axe much larger 
than in the adult animals and may have involved more inte­
grated adaptation mechanisms.
NMR experiments showed that fluxes through CK were not 
detectable in skeletal muscle of CK-deficient mice until a 
threshold of activity was reached (van Deursen et a l 1993,
1994). This suggested that bound CK fluxes are NMR invisible 
and only when CK activity reaches a certain level which allows 
saturation of binding sites, and when cytosolic CK appears, CK 
fluxes become detectable. However, contracting muscles were 
still able to hydrolyze PCr which suggested that M-CK was not 
the only enzyme catalyzing the transfer of PCr to ATP. In 
myofibrils, PCr is actively used up by bound CK; this has been 
shown in cardiac skinned fibers by the shift of the dependence 
of rigor tension development toward lower ATP concentrations 
induced by PCr (Ventura-Clapier and Veksler, 1994, for review 
see Ventura-Clapier et a l  (1994)). Although we showed th a t 
such a shift was also present in fast-twitch and slow-twitch 
control skeletal muscle fibers, it was absent in skeletal as well 
as ventricular fibers of M-CK-deficient mice. No unknown en­
zyme or other isoform of CK, retained after skinning, was thus 
present and able to use PCr and regenerate ATP inside the 
myofibrillar compartment. In M-CK-deficient mice, due to the 
absence of local rephosphorylation, ADP should accumulate in 
myofibrils and diffuse in the cytosol toward mitochondria to be 
rephosphorylated either by mitochondrial CK which could 
work in both directions, explaining utilization of PCr during 
activity, or directly through translocase and oxidative phospho­
rylations. This direct route for ADP is favored by a decreased 
K m of mitochondrial respiration for ADP, an increased mito­
chondrial network, and mitochondrial activity and increased 
glycolytic capacities (van Deursen et a l , 1993; Veksler et al
1995), Thus, alterations in one side of the CK system, i.e. 
utilization site, induces adaptations in the opposite site, i.e. 
synthesis site, showing the important role of CK in coupling 
utilization and consumption of energy inside muscle cells (for 
review see Saks et a l  (1994)).
Of primary importance to clearly understand the exact ex­
tent and limit of adaptational processes in M-CK-deficent mus­
cles is to know the kinetics of force development and, for the 
heart, to which extent it will sustain normal activity and re­
spond to adrenergic stimulation or increase in workload. A 
need for more classical but necessary physiological data is 
evident in order to infer the exact extent and limit of adapta­
tional processes as well as the real role of the specific isoen­
zymes of CK in muscle cells.
The possibility of completely and selectively abolishing a 
given function using transgenic technology is a fantastic tool 
for studying the exact role of one given protein within a path­
way or a function, or for life. It has been disappointing, how­
ever, since functions considered as essential for life could be 
suppressed without lethal or morbid consequences. However, 
considering the dynamic of life, more may be learned from the 
adaptive strategies developed during this period of high poten­
tiality which is embryonic life, in response to such specific 
alterations. It should be borne in mind that these strategies 
m ay involve “exotic” p athways an d that thorough examination
of biochemical and physiological characteristics of these ani­
mals would be of potentially high significance in the under­
standing of the role of a given pathway.
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